Institutional investors purchased a net $21.1 thousand shares of NYMX during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 1.60% of the shares outstanding that institutional investors hold is among the lowest in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BMO CAPITAL MARKETS (CANADA) Bought 13.5 Thousand shares of Nymox Pharmaceutical Corp